AXL overexpression in cancer is also correlated with poor prognosis and increased metastasis47, and AXL-mediated activation of PI3K-AKT-mTOR pathway has been linked to tumor progression and to increased proliferation of prostate cancer cells40,41. Here, AKT1 is linked to prostate carcinoma.